Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,89%
1 083,04
-9,76
-0,89%
—1 092,801 093,681 094,851 081,97——
SIXC
Communications
SIXC
Communications
SIXC
-0,39%
602,38
-2,36
-0,39%
—604,74604,74605,10601,34——
SIXE
Energy
SIXE
Energy
SIXE
+2,31%
1 242,83
+28,03
+2,31%
—1 214,801 220,811 243,821 220,81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,62%
1 713,82
-10,75
-0,62%
—1 724,571 727,021 732,301 707,43——
SIXM
Financials
SIXM
Financials
SIXM
+0,09%
639,99
+0,56
+0,09%
—639,43641,58644,53637,50——
SIXR
Staples
SIXR
Staples
SIXR
-0,20%
837,46
-1,69
-0,20%
—839,15836,90840,48832,89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,65%
214,22
-1,40
-0,65%
—215,62215,62216,21213,48——
SIXT
Technology
SIXT
Technology
SIXT
+0,78%
3 204,38
+24,86
+0,78%
—3 179,523 191,503 205,093 177,75——
SIXU
Utilities
SIXU
Utilities
SIXU
-1,23%
925,38
-11,53
-1,23%
—936,91935,42937,17923,20——
SIXV
Health care
SIXV
Health care
SIXV
-0,69%
1 442,71
-10,06
-0,69%
—1 452,771 445,931 447,431 434,91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,16%
2 361,34
-3,84
-0,16%
—2 365,182 353,642 368,102 347,80——
BIOCON:NSE
Biocon Ltd
359,60 ₹
-0,73%
(-2,65) 1K
30-apr, 14:22:37 (GMT+5:30)  ·   INR
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
BIOCON tikeri uchun statistika yaratilmoqda...
Ochish
360,50 ₹
Yuqori
361,20 ₹
Past
354,25 ₹
Bozor kapitali
582,37 mlrd
Oʻrtacha hajm
3,39 mln
Hajmi
1,43 mln
Dividend
0,14%
Choraklik dividendlar
0,12 ₹
Eks-dividend sanasi
4-iyl, 2025
P/E koeffitsiyenti
74,14
52 haftalik eng yuqori
424,95 ₹
52 haftalik eng past
317,00 ₹
Aksiya boʻyicha daromad
4,85 ₹
Muomaladagi aksiyalar
600,00 mln
Xodimlar soni
16 ming
Yangiliklar
Internetdagi manbalardan
Profil
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. The company was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA. Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Biocon Ltd haqida
CEOSiddharth Mittal
Xodimlar soni16,4 ming
Asos solingan29-noy, 1978
Bosh ofislarBangalor, Karnataka, Hindiston
Sektor-
Veb-saytbiocon.com
Keyingi hisobot: 8 kundan keyin
Pay, 7-may, 23:30
Moliya davri
Ch.4 2026
Normallashtirilgan EPS / Taxminiy
-/ (1,17 taxm.)INR
Daromad / Taxminan
-/ (45,09 mlrd taxm.)INR
Q4 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha: kelgusi tushumlarOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – INR
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – INR
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
44,17 mlrd
39,42 mlrd
42,96 mlrd
41,73 mlrd
Sotilgan mahsulotning tannarxi
22,93 mlrd
14,05 mlrd
17,72 mlrd
13,39 mlrd
Daromad narxi
22,93 mlrd
14,05 mlrd
17,72 mlrd
13,39 mlrd
Tadqiqot va ishlanmalarga xarajatlar
-370,00 mln
-346,00 mln
-132,00 mln
-531,00 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
11,62 mlrd
8,33 mlrd
9,59 mlrd
8,75 mlrd
Operatsion xarajatlar
14,18 mlrd
22,43 mlrd
21,18 mlrd
25,16 mlrd
Jami operatsion xarajatlar
37,11 mlrd
36,48 mlrd
38,90 mlrd
38,55 mlrd
Operatsion daromad
7,06 mlrd
2,94 mlrd
4,05 mlrd
3,18 mlrd
Boshqa nooperatsion daromad
-1,23 mlrd
-11,62 mlrd
94,00 mln
1,17 mlrd
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
4,87 mlrd
969,00 mln
1,71 mlrd
-678,00 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
4,36 mlrd
-11,45 mlrd
1,23 mlrd
2,26 mlrd
Daromad soligʻi boʻyicha xarajat
274,00 mln
77,00 mln
385,00 mln
-160,00 mln
Amaldagi soliq stavkasi
5,63%
7,95%
22,48%
23,60%
Boshqa operatsion xarajatlar
-1,46 mlrd
9,89 mlrd
6,72 mlrd
11,78 mlrd
Sof foyda
3,44 mlrd
314,00 mln
845,00 mln
1,44 mlrd
Sof foyda marjasi
7,80%
0,80%
1,97%
3,45%
Har bir aksiya foydasi
2,71
0,26
0,72
2,74
Foizlar va investitsiyalardan olingan daromadlar
1,12 mlrd
-
235,00 mln
-
Foizlarni toʻlash xarajatlari
-2,03 mlrd
-2,77 mlrd
-2,72 mlrd
-2,10 mlrd
Foizlarni toʻlash boʻyicha sof xarajatlar
-912,00 mln
-2,77 mlrd
-2,49 mlrd
-2,10 mlrd
Amortizatsiya ajratmalari
4,36 mlrd
4,55 mlrd
4,73 mlrd
5,15 mlrd
EBITDA
11,01 mlrd
6,89 mlrd
8,69 mlrd
7,13 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish